|
Market Closed -
Bombay S.E.
11:02:33 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 5,988.15 INR | -1.81% |
|
+0.37% | -33.54% |
| 10-16 | AstraZeneca Pharma India Limited Opens New Corporate Office in Mumbai | CI |
| 09-18 | Astrazeneca Pharma India Limited Receives Penalty Order from Registrar of Companies, Bengaluru, Karnataka | CI |
| Market Cap | 152B 1.61B 1.44B 1.33B 1.2B 2.26B 2.29B 15.97B 6.29B 79.88B 6.04B 5.91B 253B | P/E 2025 |
186x | P/E 2026 | 103x |
|---|---|---|---|---|---|
| Enterprise Value | 149B 1.57B 1.4B 1.3B 1.18B 2.21B 2.24B 15.61B 6.15B 78.11B 5.91B 5.78B 247B | EV / Sales 2025 |
12.2x | EV / Sales 2026 | 8.38x |
| Free-Float |
18.52% | Yield 2025 |
0.37% | Yield 2026 | 0.46% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ASTRAZEN | Delayed | |
NSE India S.E.
| ASTRAZEN | Delayed |
| 1 day | -1.81% | ||
| 1 week | +0.37% | ||
| Current month | -3.24% | ||
| 1 month | -10.75% | ||
| 3 months | -23.95% | ||
| 6 months | -29.13% | ||
| Current year | -33.54% |
| 1 week | 5,850 |  | 6,130.85 |
| 1 month | 5,660 | | 6,701 |
| Current year | 5,660 | | 9,219.25 |
| 1 year | 5,660 | | 9,850 |
| 3 years | 4,050.15 | | 10,653.05 |
| 5 years | 2,437.75 | | 10,653.05 |
| 10 years | 882.55 | | 10,653.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 30/06/2025 | |
| Compliance Officer | - | 22/02/2026 | |
Harish Dash
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 67 | 01/12/2016 |
| Chairman | 52 | 29/09/2024 | |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 08/11/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.81% | +0.37% | -35.62% | +30.46% | 1.61B | |
| +2.83% | +4.40% | +60.84% | +123.50% | 1,165B | |
| +3.81% | +5.66% | +38.70% | +74.91% | 645B | |
| +0.14% | +0.63% | +24.71% | +95.03% | 504B | |
| -0.26% | +2.95% | +43.74% | +64.34% | 380B | |
| -1.76% | +1.41% | +68.06% | +43.41% | 363B | |
| -0.38% | +2.89% | +22.75% | +51.83% | 297B | |
| -1.69% | +2.46% | +2.05% | +26.26% | 269B | |
| +2.04% | +3.05% | +51.12% | +60.42% | 237B | |
| +2.36% | -0.11% | +29.42% | +102.04% | 195B | |
| Average | -0.40% | +2.59% | +30.58% | +67.22% | 405.71B | |
| Weighted average by Cap. | -0.21% | +3.17% | +43.07% | +83.07% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 17.16B 181M 162M 149M 136M 254M 258M 1.8B 708M 8.99B 680M 666M 28.49B | 22.76B 240M 214M 198M 180M 337M 342M 2.38B 939M 11.92B 902M 882M 37.77B |
| Net income | 1.16B 12.22M 10.91M 10.06M 9.14M 17.15M 17.41M 121M 47.75M 606M 45.86M 44.88M 1.92B | 1.88B 19.8M 17.67M 16.3M 14.81M 27.78M 28.21M 196M 77.36M 982M 74.31M 72.72M 3.11B |
| Net Debt | -5B -52.83M -47.15M -43.5M -39.52M -74.15M -75.29M -524M -206M -2.62B -198M -194M -8.31B | -3.37B -35.58M -31.76M -29.3M -26.62M -49.94M -50.71M -353M -139M -1.77B -134M -131M -5.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | ₹5,988.15 | -1.81% | 288 |
| 22/10/26 | ₹6,098.65 | +0.36% | 199 |
| 21/10/26 | ₹6,076.90 | +0.56% | 1,073 |
| 19/10/26 | ₹6,043.30 | +1.29% | 177 |
| 16/10/26 | ₹5,966.05 | +0.73% | 117 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ASTRAZEN Stock
Select your edition
All financial news and data tailored to specific country editions
